| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.051 | 0.8 |